ZOLPIDEM TARTRATE
NDC 17224-970, ZOLPIDEM TARTRATE, tablet, from Calvin Scott & Co., Inc..
- Product NDC
- 17224-970
- Status
- Listed
- Labeler
- Calvin Scott & Co., Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077903
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/17224-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZOLPIDEM TARTRATE10 mg/1
Pharmacologic classes
Central Nervous System Depression [PE]; GABA A Receptor Positive Modulators [MoA]; gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17224-970-30 | 17224097030 | 30 TABLET in 1 BOTTLE (17224-970-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7da75d2b-905c-4fdf-bc53-1358c6477755
Use it
Look up 17224-970 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17224-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17224-970. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.